NTHI (NTHI) reported G&A of $488.71K in Q1 2026.

How has NTHI's G&A changed year-over-year?

NTHI's G&A decreased by 42.5% year-over-year, from $849.49K to $488.71K.

Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

NTHI NTHI G&A

G&A at other companies

Nuvectis Pharma, Inc.NVCT

$2.15M+14.1%

Oric Pharmaceuticals, Inc.ORIC

$8.18M+1.3%

Crinetics PharmaceuticalsCRNX

$50.83M+43.1%

Other financials

Income statement

See full

Revenue$40.0K-7.0%

Operating income-$7.1M+77.9%

Net income-$8.8M+72.7%

EPS (diluted)-$0.38+78.7%

Balance sheet

See full

Cash & equivalents$138.6K-97.5%

Total debt$666.1K—

Total equity-$13.2M-37.5%

Total assets$3.3M-60.6%

Cash flow

See full

Operating cash flow-$7.0M-23.7%

CapEx$125.0K—

Free cash flow-$5.2M—

Valuation

See full

Market cap$114.62M+51.0%

Enterprise value$115.15M+51.1%

P/S1,432.9×—

Profitability

See full

Operating margin-46,870.7%—

Net margin-51,613.3%—

FCF margin-26,083.2%—

Returns & leverage

See full

Return on equity338.1%—

Debt / equity-0.1×—

Current ratio0.1×-0.3×

Where this comes from

Reported directly by NTHI in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NTHI's G&A?: NTHI (NTHI) reported G&A of $488.71K in Q1 2026.
How has NTHI's G&A changed year-over-year?: NTHI's G&A decreased by 42.5% year-over-year, from $849.49K to $488.71K.
What does G&A mean?: Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.